SCHEMBL21152772

SCHEMBL21152772

CC(CNC(C)(C)C)CC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CASP7 P55210 1/20 0.32
KMT2A Q03164 1/20 0.32
HIF1A Q16665 1/20 0.32
ADRB2 P07550 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9407517 0.83 LMNA (0.37) LMNACYP3A4CYP2C9TSHRCASP7
SCHEMBL277394 0.78
SCHEMBL134615 0.76 TSHR (0.36) TSHR
SCHEMBL7776973 0.76 LMNA (0.33) LMNACYP3A4CYP2C9TSHRCASP7
SCHEMBL12631944 0.76
SCHEMBL18827392 0.76
SCHEMBL16183092 0.76 LMNA (0.33) LMNACYP3A4CYP2C9TSHRCASP7
SCHEMBL23660620 0.74
SCHEMBL21788480 0.74 ADRB2 (0.33) LMNACYP3A4CYP2C9TSHRCASP7
SCHEMBL17665176 0.74 GABBR2 (0.36) LMNACYP3A4CYP2C9TSHRCASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190211060-A1 CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF SIRENAS LLC (US) 2019-07-11 US disclosed
US-9850356-B2 Cellulose acylate film, polarizing plate and liquid crystal display device FUJIFILM CORPORATION (JP) 2017-12-26 US disclosed
US-20160060406-A1 CELLULOSE ACYLATE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190211060-A1 CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF VIP, NGLY1, GRPR LMNA 3869/4885CYP3A4 4381/4885CYP2C9 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.